ERD

GrapheneCore1 | Graphene-based disruptive technologies

01-04-2016

-

31-03-2018

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

01-09-2019

-

31-08-2026

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

01-05-2018

-

30-04-2025

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

01-04-2019

-

31-12-2024

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

01-11-2015

-

31-10-2023

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

INNODIA HARVEST | Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

01-05-2020

-

30-04-2024

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

01-02-2017

-

31-01-2019

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

01-01-2020

-

31-12-2024

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

01-03-2019

-

31-08-2025

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

01-01-2019

-

31-12-2025

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

PharmaLedger | PharmaLedger

01-01-2020

-

31-12-2022

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

01-01-2017

-

31-12-2024

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

FAIRplus | FAIRplus

01-01-2019

-

31-12-2022

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

01-01-2017

-

31-08-2022

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ProPAT | Robust and affordable process control technologies for improving standards and optimising industrial operations

01-01-2015

-

31-12-2018

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

TCCM | Theoretical Chemistry and Computational Modelling

01-01-2015

-

31-12-2018

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ND4ID | New Diagnostics for Infectious Diseases: “ND4ID”

01-03-2016

-

29-02-2020

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

RTCure | Rheuma Tolerance for Cure

01-09-2017

-

31-08-2023

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

ES-Cat | Directed Protein Evolution for Synthetic Biology and Biocatalysis

01-03-2017

-

30-11-2021

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

GetReal Initiative | The GetReal Initiative

01-06-2018

-

30-04-2021

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

MUSIQ | Multiphoton Microscopy and Ultrafast Spectroscopy: Imaging meets Quantum

01-04-2019

-

30-09-2023

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

iConsensus | Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

01-05-2018

-

31-10-2022

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

PhotoBioCat | Light-driven sustainable biocatalysis training network

01-01-2018

-

31-12-2021

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

InSCOPE | INternational Smart Collaborative Open-access hybrid Printed Electronics pilot line

01-01-2017

-

31-03-2020

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

MELLODDY | MachinE Learning Ledger Orchestration for Drug DiscoverY

01-06-2019

-

31-05-2022

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

EFOEUPATI | Ensuring the future of EUPATI beyond 2020

01-09-2018

-

30-09-2020

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

UBIMOTIF | Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities

01-12-2019

-

31-05-2024

Show more information

Organisation GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

Projects overview

Selected filters:

GrapheneCore1 | Graphene-based disruptive technologies

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

ConcePTION | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

INNODIA | Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

INNODIA HARVEST | Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

PharmaLedger | PharmaLedger

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

IB4SD-TRISTAN | Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

FAIRplus | FAIRplus

TransQST | Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

ProPAT | Robust and affordable process control technologies for improving standards and optimising industrial operations

TCCM | Theoretical Chemistry and Computational Modelling

ND4ID | New Diagnostics for Infectious Diseases: “ND4ID”

RTCure | Rheuma Tolerance for Cure

ES-Cat | Directed Protein Evolution for Synthetic Biology and Biocatalysis

GetReal Initiative | The GetReal Initiative

MUSIQ | Multiphoton Microscopy and Ultrafast Spectroscopy: Imaging meets Quantum

iConsensus | Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

PhotoBioCat | Light-driven sustainable biocatalysis training network

InSCOPE | INternational Smart Collaborative Open-access hybrid Printed Electronics pilot line

MELLODDY | MachinE Learning Ledger Orchestration for Drug DiscoverY

EFOEUPATI | Ensuring the future of EUPATI beyond 2020

UBIMOTIF | Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities